NRX PHARMACEUTICALS INC (NRXP) Institutional Ownership Changes & 13F Activity
NRX PHARMACEUTICALS INC (NRXP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include B Group, Inc., Ameriprise Financial Inc, Balyasny Asset Management L.P., Citadel Advisors Llc, and Vanguard Capital Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +680,043 | — | 680,043 | $2.78M | Q2 2026 | Sep 02, 2026 |
| B Group, Inc. | Buy | +1,091,767 | +36.4% | 4,091,767 | $16.74M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +928,728 | — | 928,728 | $3.80M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Buy | +893,864 | — | 893,864 | $3.66M | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +100,724 | — | 100,724 | $411.00K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +74,866 | +169.6% | 119,018 | $486.78K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -60,188 | -76.4% | 18,545 | $75.85K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +26,429 | — | 26,429 | $108.09K | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +19,308 | — | 19,308 | $78.97K | Q2 2026 | Aug 14, 2026 |
| Cresset Asset Management, Llc | Buy | +15,000 | — | 15,000 | $61.35K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +13,166 | — | 13,166 | $53.85K | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +12,305 | — | 12,305 | $50.33K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +900 | — | 900 | $3.68K | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Buy | +510 | +566.7% | 600 | $2.45K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Sell | -509 | -20.3% | 2,000 | $8.00K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Sell | -350 | -14.9% | 2,000 | $8.18K | Q2 2026 | Aug 14, 2026 |
| Vanguard Capital Management Llc | Buy | +457,975 | +39.5% | 1,618,159 | $6.62M | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +397,888 | +1577.2% | 423,115 | $1.73M | Q2 2026 | Aug 13, 2026 |
| Marshall Wace, Llp | Buy | +194,580 | — | 194,580 | $795.83K | Q2 2026 | Aug 13, 2026 |
| Renaissance Technologies LLC | Buy | +38,600 | — | 38,600 | $157.87K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Buy | +30,873 | +307.9% | 40,901 | $167.28K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +19,482 | +44.8% | 62,951 | $257.47K | Q2 2026 | Aug 13, 2026 |
| Virtu Financial Llc | Sell | -15,171 | -47.7% | 16,614 | $68.00K | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +13,138 | +7.7% | 182,718 | $747.32K | Q2 2026 | Aug 13, 2026 |
| Vanguard Global Advisers, Llc | Buy | +5,773 | — | 5,773 | $23.61K | Q2 2026 | Aug 13, 2026 |
| Geode Capital Management, Llc | Buy | +4,547 | +1.5% | 314,659 | $1.29M | Q2 2026 | Aug 12, 2026 |
| Jpmorgan Chase & Co | Buy | +34 | — | 34 | $136.00 | Q2 2026 | Aug 12, 2026 |
| Advisorshares Investments Llc | Buy | +238,551 | +56.7% | 659,018 | $2.70M | Q2 2026 | Aug 11, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +3,803 | +4695.1% | 3,884 | $15.89K | Q2 2026 | Aug 11, 2026 |
| Blackrock, Inc. | Buy | +121,465 | +122.7% | 220,460 | $901.68K | Q2 2026 | Aug 07, 2026 |
Frequently asked questions about NRXP activity
Which institutional owners are buying NRXP?
Institutional owners buying NRXP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in NRXP activity?
"Buy" means an investor increased their reported position in NRXP compared to the prior reporting period. This reflects growing exposure to NRX PHARMACEUTICALS INC (NRXP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in NRXP increasing?
Institutional interest in NRXP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related NRXP Institutional Insights
- NRXP Overview
- NRXP 13F Institutional Holders
- NRXP Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- NRXP Insider Trading & SEC Form 4 Activity
- NRXP Articles
- Top Institutional Investor Stock Rankings